Correlation Between Novo Nordisk and ProKidney Corp
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ProKidney Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ProKidney Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ProKidney Corp, you can compare the effects of market volatilities on Novo Nordisk and ProKidney Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ProKidney Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ProKidney Corp.
Diversification Opportunities for Novo Nordisk and ProKidney Corp
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novo and ProKidney is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ProKidney Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProKidney Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ProKidney Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProKidney Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ProKidney Corp go up and down completely randomly.
Pair Corralation between Novo Nordisk and ProKidney Corp
Assuming the 90 days horizon Novo Nordisk AS is expected to generate 0.7 times more return on investment than ProKidney Corp. However, Novo Nordisk AS is 1.44 times less risky than ProKidney Corp. It trades about -0.06 of its potential returns per unit of risk. ProKidney Corp is currently generating about -0.05 per unit of risk. If you would invest 10,659 in Novo Nordisk AS on November 27, 2024 and sell it today you would lose (1,603) from holding Novo Nordisk AS or give up 15.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Novo Nordisk AS vs. ProKidney Corp
Performance |
Timeline |
Novo Nordisk AS |
ProKidney Corp |
Novo Nordisk and ProKidney Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novo Nordisk and ProKidney Corp
The main advantage of trading using opposite Novo Nordisk and ProKidney Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ProKidney Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProKidney Corp will offset losses from the drop in ProKidney Corp's long position.Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
ProKidney Corp vs. Relay Therapeutics | ProKidney Corp vs. Stoke Therapeutics | ProKidney Corp vs. Pliant Therapeutics | ProKidney Corp vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |